Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 25, 2026
Why Is MaxLinear (MXL) Stock Up +11.55% Today?

Why Is MaxLinear (MXL) Stock Up +11.55% Today?

Key Takeaways

  • MaxLinear (MXL) surged 11.55% on Friday, rising roughly $9.85 to about $95.16 from a prior close of $85.31.
  • The move extended a powerful, multi-month rally driven by AI data-center demand for high-speed optical interconnect silicon.
  • Broad sector momentum lifted optical and networking chip names, with peers such as Viavi Solutions, Tower Semiconductor, GlobalFoundries, Credo Technology and Marvell Technology also advancing.
  • Renewed analyst enthusiasm — including price targets at $120 and $125 — and an S&P ratings outlook upgrade reinforced bullish sentiment.
  • Traders are now watching the company's 1.6T product ramp, upcoming earnings, and whether elevated valuations can be sustained.

Opening Summary

MaxLinear, Inc. (MXL), a semiconductor company specializing in radio-frequency, analog and mixed-signal integrated circuits — with a fast-growing franchise in optical interconnects for data centers — climbed sharply in Friday's session. Shares advanced approximately 11.55%, or about $9.85, to trade near $95.16, up from a previous close of $85.31.

The rally came as investors continued to reward the company's pivot toward the booming market for artificial-intelligence infrastructure, where its optical digital signal processors (DSPs), transimpedance amplifiers (TIAs) and drivers are in rising demand. The move was amplified by a broad advance across optical-networking and semiconductor names and by a steady stream of bullish analyst commentary.

AI Data Center and Optical Momentum

The primary driver behind the move is MaxLinear's deepening exposure to the AI data-center build-out. The company's infrastructure segment — anchored by optical interconnect products used to move data at ever-higher speeds inside hyperscale data centers — has become its largest and fastest-growing business. Management has reported infrastructure revenue growth of roughly 141% year over year in the first half of 2026, reflecting strong demand for 800G and next-generation 1.6T connectivity solutions.

Investors increasingly view MXL less as a legacy broadband chipmaker and more as a direct play on AI networking. The company's transition to Samsung for 1.6T DSP production has also been cited by analysts as a supply-chain advantage, offering customers diversification at a time when leading-edge foundry capacity is constrained.

Analyst Upgrades and Positive Ratings Actions

A wave of favorable analyst activity has supported the stock's upward trajectory. Stifel has reiterated a Buy rating with a $120 price target, while StoneX has maintained a Buy rating and a $125 target, pointing to MaxLinear's strategic positioning and growth potential in the optical market. Morgan Stanley also set a $125 price target in September.

Adding to the positive backdrop, S&P Global Ratings revised its outlook on the company to positive from negative, citing improving operational performance tied to accelerating demand for AI data-center and optical-infrastructure products. These endorsements have reinforced the market's conviction that MaxLinear's growth is durable rather than a one-quarter anomaly.

Sector Sympathy and Broader Market Context

The move did not occur in isolation. Optical-communications and networking chip stocks traded broadly higher on Friday, with names such as Viavi Solutions and Tower Semiconductor up more than 6%, and GlobalFoundries, Credo Technology, Fabrinet and Amphenol also advancing. This sector-wide strength reflects investor enthusiasm for companies exposed to AI-driven data-center capital spending.

Trading volume in MXL was elevated relative to typical levels, consistent with conviction buying. The stock's momentum has also been technically powerful: it has moved decisively above its 50-day and 200-day moving averages and is now up more than 400% year to date, placing it among the standout performers in the semiconductor complex this year.

What Comes Next for MXL

Looking ahead, investors will focus on the pace of MaxLinear's 1.6T optical ramp and its progress toward the 3.2T and 6.4T technology transitions, which management believes will increase content and average selling prices. Upcoming earnings reports and guidance updates will be key tests of whether the company can sustain its momentum.

Risks remain. The company has a history of losses and uneven cash generation, its valuation has become demanding after the multi-hundred-percent advance, and insiders have been net sellers of shares over the past year. Competition from larger, better-capitalized rivals such as AVGO and MRVL also remains a factor. Any sign of slowing data-center demand or delayed customer qualifications could test the rally.

Trending AI Robots

For traders seeking a systematic edge in volatile markets like today's, Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing users to explore approaches matched to their own objectives. Explore the Trending AI Robots to see which strategies are leading the market today.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MXL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MXL in +7.78% Uptrend, rising for three consecutive days on September 22, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MXL advanced for three days, in 254 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 08, 2026. You may want to consider a long position or call options on MXL as a result. In 70 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

The Moving Average Convergence Divergence (MACD) for MXL just turned positive on September 08, 2026. Looking at past instances where MXL's MACD turned positive, the stock continued to rise in 34 of 45 cases over the following month. The odds of a continued upward trend are 76%.

MXL moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MXL crossed bullishly above the 50-day moving average on September 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.

Bearish Trend Analysis

The 10-day RSI Indicator for MXL moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 24 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 89%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MXL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

MXL broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MXL entered a downward trend on September 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. MXL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (15.949) is normal, around the industry mean (7.892). P/E Ratio (24.331) is within average values for comparable stocks, (159.553). Projected Growth (PEG Ratio) (0.394) is also within normal values, averaging (3.726). Dividend Yield (0.000) settles around the average of (0.006) among similar stocks. P/S Ratio (10.764) is also within normal values, averaging (44.558).

The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MXL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 215.16B. The market cap for tickers in the group ranges from 86.8K to 5.49T. NVDA holds the highest valuation in this group at 5.49T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 7%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 66%. IMOS experienced the highest price growth at 27%, while MOBX experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -22%. For the same stocks of the Industry, the average monthly volume growth was 3% and the average quarterly volume growth was -55%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 52
Price Growth Rating: 44
SMR Rating: 72
Profit Risk Rating: 73
Seasonality Score: -18 (-100 ... +100)
View a ticker or compare two or three
MXL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of semiconductors and radio frequency integrated circuits

Industry Semiconductors

Industry
Semiconductors
Address
5966 La Place Court
Phone
+1 760 692-0711
Employees
1115
Web
https://www.maxlinear.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.